Default Mode Network Lateralization and Memory in Healthy Aging and Alzheimer’s Disease

Manuscript Number: 

18-0541R1

Author(s): 
Sarah J. Banks, Ece Bayram, Chris Bird, Jessica Z.K. Caldwell, Dietmar Cordes, Jeffrey Cummings, Xiaowei Zhuang

Disclosures

Sarah J. Banks

  • Nothing to Disclose

Ece Bayram

  • Nothing to Disclose

Chris Bird

  • Nothing to Disclose

Jessica Z.K. Caldwell

  • Nothing to Disclose

Dietmar Cordes

  • Nothing to Disclose

Jeffrey Cummings

  • Consulting Fees:
    Dr. Cummings has provided consultation to Acadia, Accera, Actinogen, Alkahest, Allergan, Alzheon, Avanir, Axsome, BiOasis Technologies, Biogen, Bracket, Denali, Diadem, EIP Pharma, Eisai, Forum, Genentech, Green Valley, Grifols, Hisun, Idorsia, Kyowa Kirin, Lilly, Lundbeck, MedAvante, Merck, Otsuka, Pain Therapeutics, Proclara, QR, Resverlogix, Roche, Samus, Takeda, Teva, Toyama, and United Neuroscience pharmaceutical and assessment companies.
    Equity:
    Dr. Cummings owns stock in ADAMAS, BioAsis, Prana, MedAvante, Neurokos, and QR Pharma.
    Patents/Royalties
    Copyright ownership of Neuropsychiatric Inventory (NPI).
    Grants
    • Agency: 
      Avid

Xiaowei Zhuang

  • Nothing to Disclose